Sanara Q4 net loss from continuing operations hits USD 1 million as adjusted EBITDA rises 16% to USD 5 million

Sanara MedTech, Inc. -0.72%

Sanara MedTech, Inc.

SMTI

20.62

-0.72%

  • Sanara published a quarterly and annual earnings press release reporting Q4 and full-year 2025 results and reaffirming 2026 guidance.
  • Q4 net revenue rose 5% to USD 27.5 million, or 13% excluding USD 1.8 million of BIASURGE sales in Q4 2024 tied to industry IV fluid and saline shortages following Hurricane Helene.
  • Q4 net loss from continuing operations was USD 1.1 million and adjusted EBITDA increased 14.29% to USD 4.7 million.
  • Full-year net revenue increased 19% to USD 103.1 million and adjusted EBITDA rose 86.81% to USD 17.0 million.
  • Sanara reaffirmed 2026 net revenue guidance of USD 116.0 million to USD 121.0 million, and CEO Seth Yon said the company is increasing R&D spending while focusing on the surgical operating setting.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sanara Medtech Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603240700PRIMZONEFULLFEED9677324) on March 24, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.